Market: NASD |
Currency: USD
Address: Chinachem Leighton Plaza
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. The company focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. Regencell Bioscience Holdings Limited was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
📈 Regencell Bioscience Holdings Limited Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
-
-
Upside/Downside from Analyst Target:
-
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
10-25%
-
Net Income Growth Range (1Y):
10-25%
-
Revenue Growth Range (1Y):
-
-
Upcoming Earnings Date:
2025-10-24
💰 Dividend History
| Year |
Annual Yield (%) |
Total Amount |
Current Yield (%) |
Ex Date |
Pay Date |
Particulars |
| 2025 |
- |
$38.000000 |
- |
2025-06-16 |
- |
Stock split |
|
Total Amount for 2025: $38.000000 |
📅 Earnings & EPS History for Regencell Bioscience Holdings Limited
| Date | Reported EPS |
|---|
| 2025-10-24 (estimated upcoming) | - |
| 2025-07-16 | - |
📰 Related News & Research
No related articles found for "regencell bioscience".
